CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 28 of 48

Rheumatology (Oxford)

Briefs 1,081–1,120 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    Transitioning from pediatric to adult-oriented healthcare in rheumatology: the pediatric side of the coin

    Cohort studyPediatric

  2. Rheumatology (Oxford)

    Paediatric non-infectious granulomatous uveitis: a retrospective cohort study

    Cohort studyPediatric

  3. Rheumatology (Oxford)

    Interstitial fibrosis increases the risk of end-stage kidney disease in patients with lupus nephritis

    Cohort studyLupus & APS

  4. Rheumatology (Oxford)

    Increased prevalence of malignancies in patients with IgG4-related disease: implications for clinical care

    Cohort studyAutoinflammatory & rare

  5. Rheumatology (Oxford)

    Combination of cytoplasmic and nuclear patterns on Hep-2 antinuclear antibody is useful as a screening test for anti-synthetase syndrome

    Cohort studyMyositis

  6. Rheumatology (Oxford)

    Temporal trends in mortality in patients with systemic lupus erythematosus: a Danish population-based matched cohort study

    Cohort studyLupus & APS

  7. Rheumatology (Oxford)

    Association of the multi-biomarker disease activity score with arterial 18-fluorodeoxyglucose uptake in rheumatoid arthritis

    Secondary analysisRA

  8. Rheumatology (Oxford)

    Major cardiovascular events in patients with cardiovascular monosodium urate deposits in atherosclerotic plaques

    Cohort studyGout & crystals

  9. Rheumatology (Oxford)

    Brentuximab vedotin for skin involvement in refractory diffuse cutaneous systemic sclerosis, an open-label trial

    Research articleSystemic sclerosis

  10. Rheumatology (Oxford)

    Mental health conditions in patients with systemic lupus erythematosus: a systematic review and meta-analysis

    Meta-analysisLupus & APS

  11. Rheumatology (Oxford)

    ChatGPT4’s proficiency in addressing patients’ questions on systemic lupus erythematosus: a blinded comparative study with specialists

    Cross-sectional studyLupus & APS

  12. Rheumatology (Oxford)

    Risk of chronic kidney disease in 260 patients with lupus nephritis: analysis of a nationwide multicentre cohort with up to 35 years of follow-up

    Cohort studyLupus & APS

  13. Rheumatology (Oxford)

    Prevalence and progression of arterial calcifications on computed tomography in humans with knee osteoarthritis

    Cohort studyOsteoarthritis

  14. Rheumatology (Oxford)

    Longitudinal study of patients with anti-SAE antibody-positive dermatomyositis: a multicenter cohort study in China

    Cohort studyMyositis

  15. Rheumatology (Oxford)

    Fibroblast activation protein inhibitor-positron emission tomography in aortitis: fibroblast pathology in active inflammation and remission

    Research articleVasculitis & PMR

  16. Rheumatology (Oxford)

    The clinical outcomes and healthcare resource utilization in IgG4-related disease: a claims-based analysis of commercially insured adults in the United States

    Cohort studyAutoinflammatory & rare

  17. Rheumatology (Oxford)

    Prognostic factors for colchicine prophylaxis-related adverse events when initiating allopurinol for gout: retrospective cohort study

    Cohort studyGout & crystals

  18. Rheumatology (Oxford)

    British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease

    Guideline or statementSjögren's & overlap

  19. Rheumatology (Oxford)

    Effectiveness of intravenous methylprednisolone pulse in patients with severe microscopic polyangiitis and granulomatosis with polyangiitis

    Cohort studyVasculitis & PMR

  20. Rheumatology (Oxford)

    Short-term effectiveness of guselkumab in psoriatic arthritis patients and axial involvement: results from a real-life multicentre cohort

    Cohort studySpondyloarthritis & PsA

  21. Rheumatology (Oxford)

    A direct comparison in diagnostic performance of CDUS, FDG-PET/CT and MRI in patients suspected of giant cell arteritis

    Diagnostic or prognostic studyVasculitis & PMR

  22. Rheumatology (Oxford)

    Deep learning enables automatic detection of joint damage progression in rheumatoid arthritis—model development and external validation

    Diagnostic or prognostic studyRA

  23. Rheumatology (Oxford)

    Hydroxychloroquine-induced pigmentation in rheumatic diseases: prevalence, clinical features and influencing factors

    Cross-sectional studyAcross diseases

  24. Rheumatology (Oxford)

    Incidence and risk factors of mental illnesses among patients with systemic autoimmune rheumatic diseases: an 18-year population-based study

    Cohort studyAcross diseases

  25. Rheumatology (Oxford)

    Patients with NPSLE experience poorer HRQoL and more fatigue than SLE patients with no neuropsychiatric involvement, irrespective of neuropsychiatric activity

    Secondary analysisLupus & APS

  26. Rheumatology (Oxford)

    Responsiveness and sensitivity of PROMs to change in disease activity status in early and established rheumatoid arthritis

    Secondary analysisRA

  27. Rheumatology (Oxford)

    Long-term clinical outcomes in early rheumatoid arthritis that was treated-to-target in the BeSt and IMPROVED studies

    Randomized controlled trialRA

  28. Rheumatology (Oxford)

    Dual MPO/PR3 ANCA positivity and vasculitis: insights from a 7-cases study and an AI-powered literature review

    Cohort studyVasculitis & PMR

  29. Rheumatology (Oxford)

    Systemic sclerosis-associated pulmonary arterial hypertension is characterized by a distinct peripheral T helper cell profile

    Cross-sectional studySystemic sclerosis

  30. Rheumatology (Oxford)

    Efficacy of methylprednisolone in very early systemic sclerosis: results of the ‘Hit Hard and Early’ randomized controlled trial

    Randomized controlled trialSystemic sclerosis

  31. Rheumatology (Oxford)

    Description of a novel splice site variant in UBA1 gene causing VEXAS syndrome

    Research articleAutoinflammatory & rare

  32. Rheumatology (Oxford)

    Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis

    Research articlePediatric

  33. Rheumatology (Oxford)

    Risk of diabetes mellitus in systemic lupus erythematosus: systematic review and meta-analysis

    Meta-analysisLupus & APS

  34. Rheumatology (Oxford)

    SERPINA3, FGA, AGP1, ITIH3 and SAA1 as novel biomarkers for eosinophilic granulomatosis with polyangiitis diagnosis and activity assessment

    Diagnostic or prognostic studyVasculitis & PMR

  35. Rheumatology (Oxford)

    Rheumatoid arthritis patients’ perspective on the use of prediction models in clinical decision-making

    Research articleRA

  36. Rheumatology (Oxford)

    Prevalence, characteristics, and outcome of subclinical vasculitis in polymyalgia rheumatica: a retrospective cohort study

    Cohort studyVasculitis & PMR

  37. Rheumatology (Oxford)

    Frequency and implications of malnutrition in systemic sclerosis

    Cohort studySystemic sclerosis

  38. Rheumatology (Oxford)

    Histopathological comparison of Sjögren-related features between paired labial and parotid salivary gland biopsies of sicca patients

    Diagnostic or prognostic studySjögren's & overlap

  39. Rheumatology (Oxford)

    Pharmacological interventions for early-stage frozen shoulder: a systematic review and network meta-analysis

    Meta-analysisFibromyalgia & pain

  40. Rheumatology (Oxford)

    Sarcopenia assessed by DXA and hand-grip dynamometer: a potential marker of damage, disability and myokines imbalance in inflammatory myopathies

    Case-control studyMyositis

All 1,905 Briefs in ExploreShowing Briefs 1,081–1,120 of 1,905, newest first